Table 1 Core phenotyping in DIACORE
Phenotype category | Item | Instrument for obtaining phenotype |
|---|---|---|
General | Current Medication | Q |
Ethnicity | Q* | |
Health insurance | Q | |
Disease management program | Q | |
Fasting status | Q | |
Birth weight | Q* | |
Anthropometry | Systolic and diastolic blood pressure | P |
Heart rate | P | |
Height | P | |
Weight | P | |
Waist circumference | P | |
Hip circumference | P | |
Risk factors | Diabetes duration | Q* |
Hypertension duration | Q* | |
Smoking history | Q | |
Lipid status | L | |
Physical activity | Q | |
Family history of kidney disease | Q | |
Morbidity | CAD | Q |
History of CAD (WHO Rose Angina Questionnaire) | Q | |
Myocardial infarction | Q# | |
CABG, PCI, heart valve surgery | Q# | |
PAD and carotid atherosclerosis | ||
History of PAD (Edinburgh Questionnaire) | Q | |
Vascular surgery or percutaneous intervention in peripheral and carotid vessels | Q# | |
Cerebral ischemia | Q# | |
Microangiopathy | ||
History of kidney disease and biopsy results | Q# | |
Kidney function parameters (e.g. eGFR, annual eGFR decline, albuminuria, change in albuminuria over time, dipstick urine proteinuria) | L | |
Time to doubling of serum creatinine | L§ | |
Time to incident renal replacement therapy | Q#§ | |
Diabetic retinopathy requiring laser therapy | Q# | |
History of malignancy | Q# | |
Hospitalisation | Q#§ | |
Mortality including cause | Q#§ |